Hims & Hers Health HIMS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.7%-2.1pp | 73.8%-1.2pp | 75%-1.2pp | 76.2%-0.8pp | 77%-2.4pp | |
| Operating margin | -1.3%-5.8pp | 4.5%-0.7pp | 5.2%-1.0pp | 6.2%+0.1pp | 6.2%+2.0pp | |
| Net margin | -0.6%-6.0pp | 5.5%-0.6pp | 6.1%-3.6pp | 9.6%+0.4pp | 9.2%+0.7pp | |
| EBITDA margin | 1.6%-5.2pp | 6.8%-0.3pp | 7.1%-0.6pp | 7.7%+0.3pp | 7.4%+2.1pp | |
| Free cash flow margin | 11.9%-0.9pp | 12.8%-1.1pp | 13.8%+0.8pp | 13.1%-4.6pp | 17.7%+1.2pp | |
| Returns | ||||||
| Return on equity | -2.7%-27.9pp | 25.2%-1.0pp | 26.2%-15.7pp | 41.9%+5.1pp | 36.8%+6.1pp | |
| Return on assets | -0.8%-9.8pp | 9%-0.5pp | 9.4%-7.0pp | 16.4%-8.1pp | 24.5%+2.6pp | |
| Return on invested capital | -8.5%-37.6pp | 29.1%-5.4pp | 34.5%— | —— | 37.4%+13.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×-0.1× | 1.6×+0.1× | 1.6×-0.1× | 1.7×-1.0× | 2.7×+0.1× | |
| Inventory turnover | 8.6×+0.1× | 8.5×+1.4× | 7.1×+1.9× | 5.3×-2.5× | 7.7×+0.8× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.2× | 1.9×0.0× | 1.9×-3.1× | 5×+3.4× | 1.6×-0.2× | |
| Quick ratio | 1.6×-0.1× | 1.7×+0.1× | 1.6×-2.8× | 4.5×+3.1× | 1.3×-0.2× | |
| Cash ratio | 0.4×-0.2× | 0.6×-0.2× | 0.8×-3.4× | 4.1×+3.2× | 1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.1× | 0.3×0.0× | 0.3×+0.1× | 0.1×0.0× | 0.1×+0.1× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0×0.0× | 0.1×+0.1× | |
| Net debt / EBITDA | -1.7×-1.2× | -0.5×+0.8× | -1.3×+5.5× | -6.8×-5.2× | -1.6×+1.1× | |
| Per Share | ||||||
| Book value per share | $1.95-6.7% | $2.09-10.3% | $2.34+6.6% | $2.19-1.6% | $2.23+10.6% | |
| Valuation | ||||||
| Market capitalization | $4.73B-36.0% | $7.39B-42.3% | $12.82B+33.4% | $9.61B+46.4% | $6.56B+24.3% | |
| Enterprise value | $4.67B-36.2% | $7.31B-42.1% | $12.62B+47.4% | $8.56B+34.8% | $6.35B+25.2% | |
| Price / sales | 2×-1.2× | 3.1×-2.6× | 5.8×+1.0× | 4.8×+1.1× | 3.7×+0.1× | |
| Price / book | 10.6×-3.1× | 13.7×-8.4× | 22.1×+5.0× | 17.1×+5.1× | 12×+0.9× | |
| EV / EBITDA | 124.2×+78.6× | 45.7×-34.5× | 80.1×+24.8× | 55.3×+7.3× | 48×-16.2× | |
| EV / sales | 2×-1.1× | 3.1×-2.6× | 5.7×+1.5× | 4.3×+0.7× | 3.6×+0.1× | |
| Free cash flow yield | 6%+1.9pp | 4.1%+1.7pp | 2.4%-0.3pp | 2.7%-2.1pp | 4.8%+0.2pp | |
| Earnings yield | -0.3%-2.0pp | 1.7%+0.7pp | 1%-1.0pp | 2%-0.5pp | 2.5%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Hims & Hers Health's profit margins?
- Hims & Hers Health (HIMS) runs a 71.7% gross margin and a -1.3% operating margin, with a -0.6% net margin.
- Where do Hims & Hers Health's ratios come from?
- Every ratio is computed from Hims & Hers Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
